BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7618524)

  • 1. Studies of diagnosis and pathogenesis of Wilson's disease.
    Leung X; Chen R; Liu Z; Zhang Y
    Adv Exp Med Biol; 1995; 363():197-205. PubMed ID: 7618524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Copper level and metallothionein-like Cu-binding protein in cultured skin fibroblasts from patients with Menkes' disease and Wilson's disease].
    Sato M; Hayashi A; Ito H; Tojo M; Arima M
    No To Shinkei; 1984 Nov; 36(11):1063-8. PubMed ID: 6525319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cultured skin fibroblasts: useful for diagnosis of Wilson's disease?
    Van den Berg GJ; Van den Hamer CJ; Meijer RJ; Hoogenraad TU
    J Inherit Metab Dis; 1989; 12(1):64-71. PubMed ID: 2501585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The urinary excretion of radiocopper in presymptomatic and symptomatic Wilson's disease, heterozygotes and controls: its significance in diagnosis and management.
    Gibbs K; Hanka R; Walshe JM
    Q J Med; 1978 Jul; 47(187):349-64. PubMed ID: 715173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Copper metallothionein in patients with hepatic copper overload.
    Hunziker PE; Sternlieb I
    Eur J Clin Invest; 1991 Oct; 21(5):466-71. PubMed ID: 1752285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic copper and metallothionein distribution in Wilson's disease (hepatolenticular degeneration).
    Nartey NO; Frei JV; Cherian MG
    Lab Invest; 1987 Oct; 57(4):397-401. PubMed ID: 3312808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Copper-binding proteins in liver, kidney and brain tissue from a Wilson's disease patient].
    Sato M; Arima M
    No To Shinkei; 1986 Oct; 38(10):933-41. PubMed ID: 3790358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic expression of Wilson's disease in cell culture: a diagnostic marker.
    Chan WY; Cushing W; Coffman MA; Rennert OM
    Science; 1980 Apr; 208(4441):299-300. PubMed ID: 7367859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of a stable copper isotope (65Cu) in the differential diagnosis of Wilson's disease.
    Lyon TD; Fell GS; Gaffney D; McGaw BA; Russell RI; Park RH; Beattie AD; Curry G; Crofton RJ; Gunn I
    Clin Sci (Lond); 1995 Jun; 88(6):727-32. PubMed ID: 7634759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metallothionein is elevated in liver and duodenum of Atp7b
    Zhang CC; Volkmann M; Tuma S; Stremmel W; Merle U
    Biometals; 2018 Aug; 31(4):617-625. PubMed ID: 29732486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absorption of copper in homozygotes and heterozygotes for Wilson's disease and controls: isotope tracer studies with 67 Cu and 64 Cu.
    Strickland GT; Beckner WM; Leu ML
    Clin Sci; 1972 Nov; 43(5):617-25. PubMed ID: 5083937
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of the stable isotope 65Cu test for the screening of Wilson's disease in a family with two affected members.
    Merli M; Patriarca M; Loudianos G; Valente C; Riggio O; De Felice G; Petrucci F; Caroli S; Attili AF
    Ital J Gastroenterol Hepatol; 1998 Jun; 30(3):270-5. PubMed ID: 9759594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal copper metabolism in cultured fibroblasts from patients with Wilson's disease.
    Camakaris J; Ackland L; Danks DM
    J Inherit Metab Dis; 1980; 3(4):155-7. PubMed ID: 6787337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Turnover studies of copper in homozygotes and heterozygotes for Wilson's disease and controls: isotope tracer studies with 67 Cu.
    Strickland GT; Beckner WM; Leu ML; O'Reilly S
    Clin Sci; 1972 Nov; 43(5):605-15. PubMed ID: 5083936
    [No Abstract]   [Full Text] [Related]  

  • 15. Zinc therapy increases duodenal concentrations of metallothionein and iron in Wilson's disease patients.
    Sturniolo GC; Mestriner C; Irato P; Albergoni V; Longo G; D'IncĂ  R
    Am J Gastroenterol; 1999 Feb; 94(2):334-8. PubMed ID: 10022625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of the effects of penicillamine, trientine, and trithiomolybdate on [35S]-labeled metallothionein in vitro; implications for Wilson's disease therapy.
    McQuaid A; Mason J
    J Inorg Biochem; 1991 Feb; 41(2):87-92. PubMed ID: 2033396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of the heterozygote of Wilson's disease.
    O'Reilly S; Weber P; Pollycove M; Shipley L
    J Nucl Med; 1969 Mar; 10(3):143-4. PubMed ID: 5785018
    [No Abstract]   [Full Text] [Related]  

  • 18. Low molecular weight copper binding proteins in Wilson disease.
    Rodo M; Wehr H; Wald I
    Acta Anthropogenet; 1985; 9(1-3):63-70. PubMed ID: 3843748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uneven distribution of hepatic copper concentration and diagnostic value of double-sample biopsy in Wilson's disease.
    Liggi M; Mais C; Demurtas M; Sorbello O; Demelia E; Civolani A; Demelia L
    Scand J Gastroenterol; 2013 Dec; 48(12):1452-8. PubMed ID: 24164422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies of cholecystokinin-stimulated biliary secretions reveal a high molecular weight copper-binding substance in normal subjects that is absent in patients with Wilson's disease.
    Iyengar V; Brewer GJ; Dick RD; Chung OY
    J Lab Clin Med; 1988 Mar; 111(3):267-74. PubMed ID: 3125292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.